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ABSTRACT 
 
Background: Although device-associated total joint arthroplasty (TJA) has the potential to greatly 
improve recipient quality of life, the occurrence of surgical site infection (SSI) thereafter can render 
drastically debilitating and costly consequences.  
Methods: A retrospective cohort design was used to analyze hospital discharge data from the State 
Inpatient Database (State of California, years 2009-2011). Descriptive statistics were conducted to 
establish microbial prevalence and multivariate logistic regression was conducted to examine 
associations between various patient-centric risk factors and the development of SSI. Interaction terms 
were evaluated for model inclusion. Finally, elapsed time from TJA operation to infection diagnosis was 
assessed according to site of TJA, pathogen virulence, and pre-existing comorbidities. 
Results: During retrospective review, 1769 infections were detected. The incident rate of infection was 
2.70 infections per 100,000 person-days. Staphylococci species were the most prevalent microorganisms 
(79%), including methicillin-resistant S. aureus (MRSA 24%) and methicillin-susceptible S. aureus 
(MSSA 40%). Polymicrobial aetiology was identified in 5% of infections. The multivariate logistic 
model revealed increased odds of infection were found for knee vs. hip operations (OR = 1.50; 95% CI 
= 1.41 – 1.60), for male sex (OR = 1.70; 95% CI = 1.60 – 1.80), for increasing length of hospitalization 
(OR = 1.10; 95% CI = 1.09 – 1.11), and for comorbidities including obesity (OR = 3.99; 95% CI = 3.16 
– 5.04), diabetes (OR = 1.45; 95% CI = 1.29 – 1.63), and rheumatoid arthritis (OR = 1.49; 95% CI = 
1.19 – 1.87). Diagnostic delay differed significantly according to pathogen virulence, but not with 
comorbid status and site of TJA. 
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Conclusions: Staphylococci species were the most prevalent microbes identified in infected patients. 
Anatomical site of TJA, male sex, length of hospitalization, and existing comorbidities were 
significantly associated with increased odds of surgical site infection following operative TJA. 
Surveillance networks continue to be fundamental for understanding and reducing the burden of SSI as a 
subset of healthcare-associated infections.  
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CHAPTER I: Brief Introduction 
 
 
1.1 Background 
Modern surgical procedures provide avenues to considerably improve recipient quality of life. 
However, though benefits of surgery abound, there are inherent risks associated with all surgical 
procedures. One of the most common, and devastating, complications of surgery is the occurrence of 
surgical site infection (SSI). Encompassed under the broader categorization of healthcare-associated 
infections (HAI), SSI comprise almost one third of all infections associated with seeking healthcare and 
inflict significant burden unto both the patient and the healthcare system. Risk factors for contracting 
SSI vary according to patient attributes, hospital characteristics, and type of surgical procedure. 
Additionally, resulting morbidity and the severity thereof can fluctuate with the causative pathogenic 
agent, time at which the infection was detected, and the rectifying treatment. As such, an epidemiologic 
understanding of how various risk factors and interventions contribute to the overall risk of infection 
remains an imperative pursuit in the mitigation and reduction of postoperative infections. 
1.2 Purpose of the study 
 The goal of the present study was to comprehensively and epidemiologically investigate the 
occurrence of and predisposition to SSI following total joint arthroplasty (TJA) operations. This goal 
was approached through three specific aims: 1) to determine the prevalence of microorganisms 
identified in cases of infection, 2) to examine the associations between various patient characteristics 
and the outcome of SSI in TJA recipients, and 3) to investigate the associations between procedure type, 
pathogen virulence, and existing comorbidities and the diagnostic delay from surgery to SSI detection. 
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CHAPTER II: Review of the Literature 
 
 
 
 
2.1 A portrait of total joint arthroplasty in the United States. 
 Total joint arthroplasty (TJA) is an orthopedic operation that aims to increase mobility and 
relieve pain by reconstructing deteriorated joints in the musculoskeletal system. The vast majority of 
TJA operations comprise total hip arthroplasty (THA) and total knee arthroplasty (TKA). In the past 
decade, the cumulative number of TJA operations performed in the United States exceeded two million1. 
Further, due to the growth of both the aging and obese populations, the anticipated number of TJA 
operations is projected to skyrocket1,2. Therefore, the economic and personal burdens associated with 
complications resulting from TJA should be given considerable attention.   
2.2 Aetiology of TJA surgical site infections. 
Healthcare-associated infections (HAI) are infections that manifest as a result of receiving 
treatment within a healthcare setting. In 2011, 722,000 healthcare-associated infections occurred in the 
United States, resulting in roughly 75,000 deaths3. Approximately 20-30% of all health-care associated 
infections are categorized as surgical site infections (SSI), the occurrence of which results in increased 
patient morbidity, length of hospitalization, and augmented healthcare costs in estimation of $1.6 billion 
annually4. Therefore, infection as a postoperative complication remains a high priority for infectious 
disease surveillance and remediation.  
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2.2.1 Classification of SSI 
Standardized definitions of surgical site infection are crucial to HAI surveillance efforts; such 
definitions heavily guide how infections are identified, and sequentially, how incident rates of SSI are 
determined. For TJA and other implant- or device-associated surgeries, an infection is defined as SSI if: 
it occurs within one year of surgery, it appears to be related to the initial arthroplasty operation, there is 
purulent drainage from the surgical site, and there is evidence of infection in either the deep soft tissue 
or organ/space5. Specific criteria for the diagnosis of SSI can be found in Figure 1. 
Figure 1. Definition criteria for surgical site infection following implant-related operations. 
Deep Incisional SSI  Organ/Space SSI 
 
If within one year of surgery for implantation 
AND 
Infection appears to be related to the operation 
AND 
Infection involves deep soft tissues of the incisions 
and at least one of the following: 
 
1. Purulent drainage from the deep incision 
but not from the organ/space component of 
the surgical site. 
2. A deep incision spontaneously dehisces or 
is deliberately opened by a surgeon when 
the patient has at least one of the following 
signs or symptoms: fever (>38°C), 
localized pain, or tenderness, unless site is 
culture-negative. 
3. An abscess or other evidence of infection 
involving the deep incision is found on 
direct examination, during reoperation, or 
by histopathologic or radiologic 
examination. 
4. Diagnosis of a deep incisional SSI by a 
surgeon or attending physician. 
 
 
If within one year of surgery for implantation 
AND 
Infection appears to be related to the operation 
AND 
Infection involves any part of the anatomy (e.g., 
organs or spaces) other than the incision which 
was open or manipulated during an operation and 
at least one of the following: 
 
1. Purulent drainage from a drain that is 
placed through a stab wound‡ into the 
organ/space. 
2. Organisms isolated from an aseptically 
obtained culture of fluid or tissue in the 
organ/space. 
3. An abscess or other evidence of infection 
involving the organ/space that is found on 
direct examination, during reoperation, or 
by histopathologic or radiologic 
examination. 
4. Diagnosis of an organ/space SSI by a 
surgeon or attending physician. 
 
Note: Adapted from Guideline for prevention of surgical site infection (1999). Criteria for superficial 
incisional SSI (involving only the skin and subcutaneous tissue) not reported. 
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2.2.2. Causative pathogenic agents 
i. Staphylococcal species 
The vast majority (60-80%) of infections following TJA operations are caused by gram-positive 
Staphylococci species, including methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-
resistant Staphylococcus aureus (MRSA)6. MRSA is typically associated with poorer health outcomes, 
compared to MSSA. Infections due to S. aureus are predominately endogenous in origin, meaning that 
infection emanates from the patient’s own microbial flora. Anatomically, S. aureus colonizes in the 
nostrils and on the skin; bacterial colonization is the considered the most important predictor of 
subsequent infection. For example, TJA recipients with pre-surgical nasal colonization have markedly 
increased odds of developing postoperative infection7. There are other various risk factors that can 
increase the odds of colonization, including diabetic status, the receipt of hemodialysis, and a suppressed 
immune state8.  
On a molecular level, S. aureus is a mechanistically elegant, bacterial adversary. Included in its 
arsenal are surface proteins the facilitate adhesion to and colonization of host tissues, such as those that 
surround the implanted prosthetic in TJA recipients, as well as a class of proteins known as invasins that 
allow the bacteria to spread throughout these tissues. Particularly in patients with prosthetic implants, S. 
aureus can accumulate on a biofilm on the implant surface or penetrate into the porous bone tissue9. 
Additionally, bacterial cells secrete toxins, including hemolysins and leukotoxins, which effectively lyse 
cell membranes of host tissue and immune cells, allowing bacteria to further colonize nearby tissue. As 
surface proteins, invasins, and toxins actively promote the spread of S. aureus throughout the tissue, 
other virulence factors play a defensive role in evading the host immune system. Protein A and another 
protein known as coagulase coat the bacterial cell membrane and inhibit phagocytosis. Coagulase 
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induces blood clotting in a way that forms a protective barrier around the microorganism; therefore 
macrophages and other responding immune cells cannot engulf it10. Certain strains of S. aureus known 
as coagulase-negative S. aureus (CoNS) lack the ability to synthesize coagulase; CoNS bacteria are 
generally categorized as less virulent that MRSA and MSSA. S. aureus also evades neutrophils by 
secreting proteins that can block neutrophil recognition of antigenic sequences, allowing the foreign 
invader to remain undetected while it continues to spread. For S. aureus, the adaptive immune response 
usually occurs within 7-10 days and will manifest as swelling, tenderness, neat, and pain near the 
prosthetic implant10.  
ii. Gram-negative enteric bacilli 
Although gram-positive species predominate as the causative pathogens in infections following TJA, 
there has been an observed increase in the number of infections due to gram-negative bacilli (GNB)11. 
GNB comprise several species of bacteria, including Escherichia coli, Pseudomonas aeruginosa, 
Acinetobacter baumannii, and various enterococci species12. Many of these microorganisms exhibit 
some form of antimicrobial resistance, and are thus categorically considered quite virulent relative to 
other pathogens. Early and appropriate treatment of GNB infection results in reduced mortality and 
morbidity; however, within the context of TJA in which diagnosis often delayed, infections caused by 
GNB can be extensively detrimental. Therefore, though GNB are most frequently associated with other 
categories of HAI, such as respiratory tract infections, catheter-associated urinary tract infections, and 
bloodstream bacteremia12, recent evidence suggests that GNB may soon play a larger pathogenic role in 
the category of surgical site infections. As such, prevalence of GNB isolated from SSI following total 
joint arthroplasty should be carefully monitored in future microbial surveillance. 
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2.2.3 Treatment protocol. 
Upon official diagnosis SSI, the process of infection management and remediation may begin. 
The time at which the infection is diagnosed heavily guides the course of treatment. For patients with a 
diagnostic delay less than 30 days from index surgery, or an estimation of less than 3 weeks from 
symptom onset, debridement of the infected bone/tissue and retention of the implant is an acceptable 
treatment option13. It should be noted that retention of the original implant may contribute to a higher 
risk of infection relapse, and should therefore only be considered for patients in which infection was 
detected early and for whom additional surgery is exceptionally risky. For patients that present with 
infection greater than 30 days after surgery, a more intensive course of action is required. As with earlier 
diagnoses, the tissue and bone surrounding the joint is sufficiently debrided and scourged of biofilm13,14. 
However, in delayed cases, effective infection control paradigm mandates the subsequent removal of the 
prosthetic implant and replacement with an antibiotic-laden cement spacer that acts a temporary 
placeholder. Though rare, in extensively severe cases infection the best course of action may in fact be 
amputation of afflicted limbs. Figure 2 details the decision process of determining if implant retention a 
possibility.	  	  
 
Figure 2. Decision diagram in determining 
the proper course of treatment following 
infection diagnosis13. 
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Following surgical remediation, six to eight weeks of appropriate antibiotics are intravenously 
administered to clear any remaining infection. Current recommendations for clinicians regarding 
antibiotic delivery and duration can be found in Figure 3. Finally, once the patient has been declared free 
of infection, the process may begin anew with a revision TJA procedure, with hopes of a better outcome 
than the initial attempt. Though the degrees of infection severity may vary, the treatment protocol for 
each is inarguably tedious, additionally invasive, and usually a source of great frustration for the patient 
and provider alike. 
 
Figure 3. Recommended course of antibiotic treatment according to causative pathogen13. 
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2.3 Identified risk factors in the extant literature. 
The predisposition to SSI following TJA is facilitated by a complex array of risk factors, both 
patient-centric and healthcare provider-related in origin. Patient-related factors include increased age, 
male sex, smoking status, higher American Society of Anesthesiologist (ASA) score, previous operation 
history, and existing comorbidities such as diabetes mellitus, obesity, and rheumatoid arthritis15-23. 
Identified healthcare-associated factors include hospital case volume, length of operation, length of 
hospitalization, and the administration of antibiotic prophylaxis15,17,18,20. The implementation of 
surveillance networks such as the National Healthcare Safety Network (NHSN) has been decidedly 
helpful in elucidating healthcare-association factors that may predict infection. Such networks dictate 
strict standards for documenting relevant, comprehensive intricacies concerning treatment in healthcare 
facilities. For instance, the length of operation in minutes, the exact specification of antibiotic 
prophylaxis administered perioperatively, and detailed assessments of patient health (i.e., lab data, ASA 
score) are all procedure-related data elements collected by NHSN and analogous networks that may 
have been otherwise unavailable. Finally, though many risk factors have been independently implicated 
throughout the literature, the interplay between both patient and hospital factors, and the resulting 
impact on risk for SSI, remains yet to be clearly understood. Therefore, future research should not only 
build on the existing knowledge of infection risk factors following total joint arthroplasty, but should 
additionally investigate novel ways in which these risk factors may interact or compound.  
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CHAPTER III: Original Research Manuscript 
 
Surgical Site Infection Following Total Joint Arthroplasty: An Examination of Microbial Isolates, 
Predisposing Patient Factors, and Diagnostic Delay.  
 
ABSTRACT. 
 
Background: Although device-associated total joint arthroplasty (TJA) has the potential to greatly 
improve recipient quality of life, the occurrence of surgical site infection (SSI) thereafter can render 
drastically debilitating and costly consequences.  
Methods: A retrospective cohort design was used to analyze hospital discharge data from the State 
Inpatient Database (State of California, years 2009-2011). Descriptive statistics were conducted to 
establish microbial prevalence and multivariate logistic regression was conducted to examine 
associations between various patient-centric risk factors and the development of SSI. Interaction terms 
were evaluated for model inclusion. Finally, elapsed time from TJA operation to infection diagnosis was 
assessed according to site of TJA, pathogen virulence, and pre-existing comorbidities. 
Results: During retrospective review, 1769 infections were detected. The incident rate of infection was 
2.70 infections per 100,000 person-days. Staphylococci species were the most prevalent microorganisms 
(79%), including methicillin-resistant S. aureus (MRSA 24%) and methicillin-susceptible S. aureus 
(MSSA 40%). Polymicrobial aetiology was identified in 5% of infections. The multivariate logistic 
model revealed increased odds of infection were found for knee vs. hip operations (OR = 1.50; 95% CI 
= 1.41 – 1.60), for male sex (OR = 1.70; 95% CI = 1.60 – 1.80), for increasing length of hospitalization 
(OR = 1.10; 95% CI = 1.09 – 1.11), and for comorbidities including obesity (OR = 3.99; 95% CI = 3.16 
– 5.04), diabetes (OR = 1.45; 95% CI = 1.29 – 1.63), and rheumatoid arthritis (OR = 1.49; 95% CI = 
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1.19 – 1.87). Diagnostic delay differed significantly according to pathogen virulence, but not with 
comorbid status and site of TJA. 
Conclusions: Staphylococci species were the most prevalent microbes identified in infected patients. 
Anatomical site of TJA, male sex, length of hospitalization, and existing comorbidities were 
significantly associated with increased odds of surgical site infection following operative TJA. 
Surveillance networks continue to be fundamental for understanding and reducing the burden of SSI as a 
subset of healthcare-associated infections.  
 
KEYWORDS: healthcare-associated infections, total joint arthroplasty, surveillance 
 
 
Introduction. 
 Though there are numerous benefits associated with total joint arthroplasty (TJA) operations, the 
development of subsequent surgical site infection (SSI) can be catastrophically detrimental to both the 
patient and the healthcare system. The occurrence of SSI as a postoperative complication results in 
increased patient morbidity, length of hospitalization, and augmented healthcare costs in estimation of 
$1.6 billion annually1, 2. Further, the growing number of TJA procedures in the United States and abroad 
will only serve to amplify these debilitating and costly impacts3. Understanding the associations between 
various patient- and provider-mediated risk factors and the contraction of SSI through epidemiologic 
investigations is a requisite first step in mitigating the deleterious effects of such infections.  
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It is estimated that SSI account for approximately 20-30% of all health-care associated 
infections4. Currently, the incident rate of SSI for TJA procedures ranges from 0.72 to 2.71 infections 
per 100 arthroplasties performed5-8; however, these rates almost certainly underestimate the true 
population incidence as the majority of SSI occur after hospital discharge, with some cases remaining 
undocumented. The magnitude of this incident rate is associated with several previously identified risk 
factors, both patient-related and healthcare-associated in nature. Patient-related factors include increased 
age, male sex, smoking status, higher American Society of Anesthesiologist (ASA) score, previous 
operation history, and existing comorbidities such as diabetes mellitus, obesity, and rheumatoid 
arthritis6-14. Identified healthcare-associated factors include hospital case volume, length of operation, 
length of hospitalization, and the administration of antibiotic prophylaxis6, 8, 9, 11. While some of these 
factors are non-modifiable (e.g., age, sex), many are to some degree malleable. Therefore, efforts to 
reduce SSI following TJA operations may be most effectively pursued by targeting preventive measures 
towards these select modifiable sources of risk.   
Sequentially, it is directly pertinent to the surveillance of healthcare-associated infections to 
identify which microorganisms are most commonly responsible for SSI development. Currently, the vast 
majority (60-80%) of infections following TJA are caused by gram-positive Staphylococci species, 
including methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus 
aureus (MRSA), methicillin-resistant Staphylococcus epidermis (MRSE), and coagulase-negative 
staphylococci (CoNS)5, 15. However, while staphylococcal species predominate as the causative 
pathogens of TJA postoperative infection, evidence suggests that other species may be emerging as 
prevalent bacterial threats. For example, increases in the proportion of infections caused by gram-
negative bacilli (GNB) have been observed16. Temporal changes are not only limited to species 
prevalence, but extend also to the diversity of coexisting microbial species at the site of infection. 
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Although most infections are monomicrobial (i.e, only one species present), trends from the past decade 
indicate an increase in the number of polymicrobial infections (i.e., multiple species of microbes) 
following TJA operations16. Patients with polymicrobial infections generally have poorer health 
outcomes, as compared to monomicrobial infections17. This temporal shift in pathogenic prevalence and 
diversity, particularly with regard to resistant species, may have important implications for antibiotics 
prescribed both prophylactically and for infection management and remediation.  
Though a growing body of infection control literature exists examining the risk factors for the 
absolute occurrence of SSI, less is known about how these implicated risk factors are associated with the 
timing of SSI symptom onset and detection. Conventionally, infection diagnosis after TJA is categorized 
as early (less than three months), delayed (three months to two years), or late (greater than two years), 
respective to index date of surgery18. Certain factors may influence the likelihood that an infection will 
be diagnosed as either early, delayed, or late. Previous research has indicated that the procedure type 
may account for differential timing in detection among TJA recipients, with 25% of total knee 
arthroplasties diagnosed as delayed, in contrast to only 9% delayed detection among total hip 
arthroplasties19, 20. Pathogen virulence may also have implications for the delay from surgery to 
diagnosis. More virulent pathogens such as S. aureus and gram-negative bacilli may induce more severe 
and proximally manifesting symptoms than less virulent species (i.e., coagulase-negative staphylococci, 
enterococci, and streptococci). The severity of symptoms stemming from more virulent pathogens may 
prompt patients to seek healthcare sooner, ultimately leading to an earlier diagnosis of SSI. The time-
from-surgery at which infections are detected is intrinsic to determining the appropriate course for 
management and treatment20, 21. Therefore, more research is needed that examines the relationship 
between relevant risk factors and the time to SSI detection. 
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 The aims of the current epidemiologic study were 1) to determine the prevalence of 
microorganisms identified in cases of infection, 2) to examine the associations between various patient 
characteristics and the outcome of SSI in TJA recipients, and 3) to investigate the associations between 
procedure type, pathogen virulence, and existing comorbidities and the diagnostic delay from surgery to 
SSI detection. 
Methods. 
This retrospective cohort study utilized hospital discharge data from the State Inpatient Database 
(SID) aggregated by the Healthcare Utilization Project (HCUP). Participating hospitals report inpatient 
discharge data on a yearly basis; all discharge data is reported, regardless of payment source or 
insurance affiliation. In this way, a surveillance system is created that yields a fairly representative 
sample of all inpatient services, including patient characteristics, diagnoses and procedures, and details 
about hospitalization. For the current study, data from the State of California (years 2009-2011) were 
analyzed. Particularly, the California SID was selected because of its thoroughness and inclusion of 
revisit linkage variables, which enabled the identification of patient readmission across multiple years 
and hospitals. The appropriate Institutional Review Board approval for this study was obtained prior to 
data management and analysis.  
Study Sample. 
Records of all TJA operations performed in the years 2009-2011 were reviewed retrospectively. 
Total hip arthroplasty and total knee arthroplasty procedures were identified through their respective 
International Classification of Disease 9th Revision (ICD-9) procedure codes. For the purposes of this 
study, only records indicating primary TJA operations were included for analysis. Documentation of 
codes used for data management and sample inclusion can be found in Appendix A. 
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Outcome Assessment. 
The primary outcome of interest was the development of surgical site infection. The medical 
records of TJA patients were prospectively monitored for a period of 12 months. Previous research has 
indicated that one year is an appropriate surveillance time for identifying postoperative infections, 
corroborated by infection classification criteria for implant-associated operations. Infections were 
defined as patients who underwent TJA and were subsequently readmitted with a surgical site infection 
code within 12 months of index surgery. Non-infections were defined as TJA recipients that did not 
readmit for surgical site infection within 12 months of index surgery. ICD-9 codes were used to 
determine if the principal diagnosis was infection or inflammation resulting from prosthetic implant, and 
for identification of the causal microorganism (see Appendix A). All diagnoses on record were 
evaluated in order to determine the principal diagnosis. Individuals that underwent TJA in the terminal 
year of the study timeframe (2011) that did not develop SSI prior to the end of the year were excluded 
from risk factor analysis, as their records could not be prospectively monitored for an entire 12 months.  
Patient Characteristics. 
Patient characteristics were extracted from discharge reports for the inpatient stay associated 
with the initial TJA operation. Patient demographics such as age, sex, and race, as well as general 
patient health and comorbidities were considered relevant for analysis. Temporal variables such as 
length of hospitalization and time lapse from surgery to infection detection were elucidated, and 
continuous variables were evaluated for normality. All data management and statistical analyses were 
conducted using SAS 9.4 (SAS, Cary, NC). 
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Statistical Analyses. 
Descriptive statistics were conducted to determine frequencies of patient characteristics and the 
incident rate of SSI. Incident rate (IR) was calculated as: 
𝐼𝑅 = 𝑛𝑒𝑤  𝑐𝑎𝑠𝑒𝑠  𝑜𝑓  𝑆𝑆𝐼𝑡𝑜𝑡𝑎𝑙  𝑛𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑝𝑒𝑟𝑠𝑜𝑛𝑑𝑎𝑦𝑠  𝑎𝑡  𝑟𝑖𝑠𝑘 
This IR is calculated from a preliminary sample (n = 222,078) including TJA recipients that were 
eventually excluded from the analyses for microbial prevalence, patient risk factors, and diagnostic 
delay. 
Microbial Prevalence. 
Descriptive statistics were used to determine the prevalence of microorganisms indicated on 
patient records for the inpatient stay at the time of SSI discovery. All additional diagnoses on the patient 
chart were evaluated for microbial identification by their corresponding ICD-9 codes. Polymicrobial 
aetiology was flagged as the presence of more than one pathogen on the patient record. Fisher’s exact 
test was conducted to compare the distribution of microbial prevalence by anatomical site of TJA (hip 
vs. knee).  
Patient Risk Factors. 
 Logistic regression analyses were conducted to examine the association between patient 
characteristics and the outcome of SSI. Univariate analysis was conducted to determine the independent 
association of each risk factor with infection. All risk factors that were significantly associated with the 
outcome as well as with other risk factors were evaluated as potential sources of confounding and effect 
modification. Characteristics with significant associations in univariate analysis were included in the 
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multivariate logistic regression model in order to calculate adjusted odds ratios. Interaction terms were 
also assessed. Akaike Information Criterion (AIC) and Hosmer-Lemeshow goodness-of-fit statistics 
were given consideration for determining best-fit model selection. 
Diagnostic Delay. 
 Among patients that developed SSI, Wilcoxon rank sum non-parametric t-test for independent 
samples was used to compare median diagnostic delay across anatomical site of TJA (hip vs. knee), 
pathogen virulence (less virulent vs. more virulent), and comorbid status (no comorbidities vs. one or 
more comorbidities). Diagnostic delay was defined as the difference from the time of initial TJA 
operation to time of infection diagnosis. 
Results. 
For this sample, 1769 surgical site infections were diagnosed. The incident rate of infection for 
this sample was 2.70 infections per 100,000 person-days at risk. 
Microbial Prevalence. 
Microbial isolates were identified in 46% of infections. Staphylococci species were implicated in 
the vast majority (78.9%) of infections, including 39.6% methicillin-susceptible Staphylococcus aureus 
(MSSA) and 24.3% methicillin-resistant Staphylococcus aureus (MRSA). Approximately 10.5% of 
infections were caused by gram-negative bacilli (GNB), comprised of Eschrichia coli (1.3%), 
Pseudomonas species (4.5%), and unspecified GNB (4.7%). Polymicrobial infections were identified in 
4.7% of all SSI. Frequencies of microorganisms for all infections and according to anatomical site of 
TJA are reported in Table 1. Further, the distribution of microbial prevalence differed significantly 
between hip and knee operations. (p < 0.0001). 
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Patient Risk Factors. 
A total of 146,492 TJA operations were identified through retrospective review (34% total hip 
arthroplasty, 66% total knee arthroplasty) and included in the final analytic sample. Median age was 
67.0 years (IQR 60.0 – 75.0), and the majority of TJA recipients were female (60.1%). Most recipients 
were Caucasian (77.7%). Median length of hospitalization for the inpatient stay surrounding the 
procedure was 3.0 days (IQR 3.0 – 4.0). 
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Univariate analysis revealed that all risk factors were significantly associated with the outcome 
of SSI (Table 2). Although many variables were significantly associated with both the outcome and 
additional patient characteristics, none were deemed to be sources of confounding. Forward selection 
identified 4 statistically significant interaction terms. Models containing all possible combinations of 
these interaction terms were evaluated. The final model that yielded minimum the AIC value and p > 
0.05 for the Hosmer-Lemeshow χ2 goodness-of-fit test contained 3 interaction terms: obesity x TJA site, 
obesity x sex, and obesity x length of hospitalization. 
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After logistic regression in the multivariate model, all variables but hypertension and race 
remained significantly associated with the outcome of SSI (Table 3). Increased odds of infection were 
found for knee vs. hip operations (OR = 1.50; 95% CI = 1.41 – 1.60), for male sex (OR = 1.70; 95% CI 
= 1.60 – 1.80), for increasing length of hospitalization (OR = 1.10; 95% CI = 1.09 – 1.11), and for 
comorbidities including obesity (OR = 3.99; 95% CI = 3.16 – 5.04), diabetes (OR = 1.45; 95% CI = 1.29 
– 1.63), and rheumatoid arthritis (OR = 1.49; 95% CI = 1.19 – 1.87). Increasing age was determined to 
be very slightly protective against SSI (OR= 0.99; 95% CI = 0.98 – 0.99). 
 
 
Diagnostic Delay. 
Median time delay from surgery to infection diagnosis was significantly greater for less virulent 
pathogens (60 days, IQR = 27 – 160) compared to more virulent pathogens (38 days, IQR = 20 – 98)    
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(p < 0.0001). Diagnostic delay did not differ with comorbid status (no comorbidities vs. one or more 
comorbidities) or anatomical site of TJA operation (hip vs. knee).  
Discussion. 
 For the majority of recipients, TJA is a highly beneficial operation that improves range of 
motion, mobility, and quality of life generally. However, for the small subset of patients who go on to 
develop subsequent surgical site infection, the operative experience becomes tainted by further pain and 
debilitation, frustration, and augmented healthcare costs. And while advances in infection prevention 
and control continue to emerge, this epidemiological study and others demonstrate that SSI remains a 
notable occurrence following total joint arthroplasty operations.  
Microbial Prevalence. 
The overall cumulative rate of infection for this sample was 1.2%, similar to rates previously 
established throughout the extant literature5-8. The incident rate of infection was 2.70 infection per 
100,000 person-days of follow-up time. In congruence with microbial prevalence determined in other 
studies5,16, Staphylococci species were the most common microorganisms isolated from infected 
patients. Methicillin-susceptible Staphylococcus aureus (MSSA) was the most prevalent pathogen 
(39.6%), followed by methicillin-resistant Staphylococcus aureus (MRSA; 24.3%). These findings 
demonstrate that antibiotic-resistant species continue to present a notable threat with regards to health-
care associated infections; therefore, special consideration should be given to which antibiotics are 
prescribed prophylactically and perioperatively. For this sample, the proportion of polymicrobial 
infections was comparatively small (5%) compared to those found in other studies (46%)16. The 
distribution of pathogens differed significantly in hip and knee operations, however, the biological 
mechanisms for this finding are unclear. A worthwhile addendum to this analysis would be to 
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investigate which patient characteristics are associated with the susceptibility to specific microbes; that 
is, could patient attributes potentially predict the causative microorganism in cases of infection?  
Patient Risk Factors. 
 The patient characteristics investigated in this study were age, sex, race, anatomical site of TJA, 
length of hospital stay associated with the TJA operation, and patient comorbidities existing at the time 
of surgery. Patients who received joint replacement at the knee had 1.5 times the odds of developing 
surgical site infection as compared to those who underwent joint replacement at the hip (95% CI = 1.41 
– 1.60). Length of inpatient stay surrounding the initial arthroplasty operation was also statistically 
significant (OR = 1.10; 95% CI = 1.09 – 1.11). Though the magnitude of this association was relatively 
small compared to the contributions from other risk factors, it aligns with previous findings. A longer 
hospitalization may result from complications during or immediately after surgery, as well as patient 
vulnerabilities that may necessitate a longer period of observation post-operation. It would not be 
imprudent to infer that such complications and vulnerabilities might supplement the odds of developing 
infection. 
 When regressed in the multivariate model, all comorbidities except hypertension were 
significantly associated with SSI. Of these comorbidities, obesity had the largest associative measure 
(OR = 3.99, 95% CI = 3.16 – 5.04). In fact, the relationship between obesity and the outcome of SSI was 
the strongest relative to all other patient characteristics analyzed. Further, all significant interaction 
terms that improved model fit contained an obesity component. This finding has substantial implications 
for practice and prevention. Obesity not only contributes heavily to the risk of SSI development, but 
perhaps more encouraging, is largely modifiable. Obese status should be given due consideration when 
evaluating a patient for TJA operation potential. With acknowledgement that the lack of mobility that 
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often necessitates TJA may add to or exacerbate patient obesity, healthcare providers should suggest that 
patients take safe measures to reduce BMI to a non-obese status, when possible. 
Interestingly, increasing age was found to very slightly protective against infection (OR = 0.99, 
95% CI 0.98 – 0.99). This finding contradicts associations elucidated in other studies, in which older age 
increases the odds of SSI or is not significantly associated at all. However, the odds ratio obtained for 
this sample, though significant, is substantially close to and tightly clustered around OR = 1. Therefore, 
from a clinically practical perspective, it would be unwise to advocate that increased age is a protective 
factor. More research is needed to determine a more concrete and universal understanding of the 
relationship between age and development of SSI after TJA, as well as what other factors may confound 
this relationship. 
Diagnostic Delay. 
 Prior research suggests that the time lapse from index TJA surgery to detection of SSI may be 
influenced by a variety of factors. In this sample, diagnostic delay differed significantly according to 
degree of pathogen virulence, but not by anatomical site of TJA or comorbid status. The severity of 
symptoms stemming from more virulent pathogens may prompt patients to seek healthcare sooner, 
which may explain why infections in the sample caused by more virulent microbes such as S. aureus and 
GNB were detected almost a full month sooner than those caused by less virulent organisms. An earlier 
detection of SSI implies earlier management and treatment administration. Considering that it is 
treatment paradigm to 1) first remove the infected implant and place an antibiotic-laden spacer until 
infection has cleared (approximately 6 weeks), and 2) to then perform another TJA surgery for which 
recovery time approximates an additional 6-8 weeks, expediting this rehabilitation process through 
earlier detection is undeniably advantageous. It should be noted that this investigation, as well as many 
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others throughout the literature, use the time of infection diagnosis as a proxy for the time of event 
occurrence. In reality, symptom onset and clinically detectable levels of infection most likely occur days 
to weeks prior to diagnosis. Therefore, though time and resource intensive, prospective cohort studies in 
which biological samples are regularly extracted and examined may illuminate more precisely the exact 
timing and natural history of surgical site infection following TJA operations, and sequentially, how 
patient and pathogen characteristics affect this timing.  
Strengths and Limitations. 
 This investigation exhibits many strengths. Firstly, the dataset from which the sample was drawn 
is deemed to be fairly representative of inpatient visits nationally. Additionally, due to the size and 
inclusiveness of the data, the sample size of the population of interest (TJA recipients) was relatively 
large (n = 146,692). Given the small rate of infection that is generally expected for SSI following 
arthroplasty operations, a large population sample is favorable. Finally, the retrospective study design 
used for this examination is preferable for investigating comparatively rare disease outcomes. 
However, various limitations must also be addressed. The largest drawback of this study is that it 
limits risk factor assessment to only those patient characteristics available on the medical record. Data 
pertaining to details surrounding hospitalization (i.e., length of operation and administration of antibiotic 
prophylaxis) would substantially enhance the predictive potential of the multivariate logistic regression 
model and more accurately estimate measures of association. This point emphasizes the importance of 
continued, standardized maintenance of infection surveillance networks such as the National Healthcare 
Safety Network (NHSN) for all inpatient services. Such networks annotate more comprehensively the 
procedural factors may be relevant to development of later infection or complications that result from 
seeking healthcare. Additionally, data from only one state were used. Therefore, it is possible that if a 
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patient had a TJA operation in-state, and then moved out of state and subsequently developed SSI, that 
infection would not be included in the current calculated rate. Therefore, this incident rate calculated for 
this study most likely underestimates the true population rate. Integration of data across all states would 
greatly strengthen future epidemiological investigations. Finally, the use of forward selection in model 
determination may have excluded biologically, though not statistically, important interactions. 
Conclusions. 
Staphylococci species were the most prevalent microbes identified in infected patients. 
Anatomical site of TJA, male sex, length of hospitalization, and existing comorbidities were 
significantly associated with increased odds of surgical site infection following operative TJA. 
Particularly, the modifiable risk factor of comorbid obesity enumerated the largest measure of 
association for the outcome of infection; therefore, efforts to reduce obesity in TJA candidates may in 
turn reduce the rate of SSI. Infections caused by more virulent pathogens were detected earlier than 
those caused by less virulent pathogens, though median time to diagnosis in both categories was still 
considered early by conventional classification. Finally, surveillance networks continue to be 
fundamental for understanding the relationship between various patient-centric and healthcare provider-
related risk factors, and the potential reduction of surgical site infection as a subset of healthcare-
associated infections. 
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